Bone mineral density in end-stage renal disease patients: Association with wasting, cardiovascular disease and mortality

Blood Purification

Volumn 26, Issue 3, 2008, Pages 284-290

  Matsubara, Keisuke ^a   Suliman, Mohamed E ^a   Qureshi, Abdul Rashid ^a   Axelsson, Jonas ^a   Martola, Leena ^a   Heimbürger, Olof ^a   Barany, Peter ^a   Stenvinkel, Peter ^a   Lindholm, Bengt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mineral density; Cardiovascular disease; End stage renal disease; Inflammation; Mortality; Vascular calcification; Wasting

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BONE DENSITY; CARDIOVASCULAR DISEASE; CAROTID ARTERY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OSSIFICATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SWEDEN; WASTING SYNDROME;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; CARDIOVASCULAR DISEASES; CAROTID STENOSIS; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INFLAMMATION; INTERLEUKIN-6; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MALNUTRITION; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SMOKING; SURVIVAL ANALYSIS; SWEDEN; WASTING SYNDROME;

EID: 44349110202     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000126925     Document Type: Article

References (35)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
2. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9(12 suppl):S16-S23.
3. Stenvinkel P, Pecoits-Filho R, Lindholm B: Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003;14:1927-1939.
4. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
5. Querfeld U: Is atherosclerosis accelerated in young patients with end-stage renal disease? The contribution of paediatric nephrology. Nephrol Dial Transplant 2002;17:719-722.
6. Asaka M, Iida H, Entani C, Fujita M, Izumino K, Takata M, et al: Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin Nephrol 1992;38:149-153.
7. Eeckhout E, Verbeelen D, Sennesael J, Kaufman L, Jonckheer MH: Monitoring of bone mineral content in patients on regular hemodialysis. Nephron 1989;52:158-161.
8. Gabay C, Ruedin P, Slosman D, Bonjour JP, Leski M, Rizzoli R: Bone mineral density in patients with end-stage renal failure. Am J Nephrol 1993;13:115-123.
9. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-617.
10. Bushinsky DA: Bone disease in moderate renal failure: cause, nature and prevention. Annu Rev Med 1997;48:167-176.
11. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, et al: Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995;47:1434-1442.
12. Bushinsky DA: The contribution of acidosis to renal osteodystrophy. Kidney Int 1995;47:1816-1832.
13. Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ: Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 1996;28:515-522.
14. Hamerman D: Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM 2005;98:467-484.
15. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
16. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, et al: Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998;53:773-782.
17. Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ: Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 2003;63:1116-1120.
18. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-137.
19. Prentice A: The relative contribution of diet and genotype to bone development. Proc Nutr Soc 2001;60:45-52.
20. Prentice A: Diet, nutrition and the prevention of osteoporosis. Public Health Nutr 2004;7:227-243.
21. Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR: Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 2000;15:1974-1980.
22. von der Recke P, Hansen MA, Hassager C: The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999;106:273-278.
23. Browner WS, Seeley DG, Vogt TM, Cummings SR: Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 1991;338:355-358.
24. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A: Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 1997;28:1730-1732.
25. Schmid K, McSharry WO, Pameijer CH, Binette JP: Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 1980;37:199-210.
26. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-1809.
27. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT: Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994;94:1597-1604.
28. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.
29. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, et al: Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.
30. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
31. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, et al: osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-1268.
32. Heinonen A, Kannus P, Sievanen H, Oja P, Pasanen M, Rinne M, et al: Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 1996;348:1343-1347.
33. Stack AG, Molony DA, Rives T, Tyson J, Murthy BV: Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis 2005;45:690-701.
34. Yildiz A, Tepe S, Oflaz H, Yazici H, Pusuroglu H, Besler M, et al: Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients. Nephrol Dial Transplant 2004;19:885-891.
35. Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD: Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 1993;307:172-173.